Evercore HC Menlo vs Lazard HC SF
Curious on how these two groups stack up against one another in terms of deal flow, culture, pay, and overall the better place to work (objectively).
Curious on how these two groups stack up against one another in terms of deal flow, culture, pay, and overall the better place to work (objectively).
| +150 | Senior Banker's Guide to IB Recruiting / Group Placement (with a Healthcare Bent) | 22 | 2h |
| +135 | As Lehman people reconvene at UBS, Barclays needs to hire (2023) | 21 | 2h |
| +123 | Is pay at BofA really that bad? | 60 | 14h |
| +88 | Day at Macquarie | 12 | 14h |
| +44 | Is the life of a VP at a 'top-bank' really good? | 15 | 3d |
| +44 | How bad did I mess up | 10 | 20h |
| +31 | Misrepresented Houston IB | 14 | 1d |
| +29 | Law school instead of MBA for RX Banking | 6 | 18h |
| +29 | No BB RO 2026 | 10 | 2d |
| +28 | JPM SMALL CAP or WF/JEF/RBC Coverage group | 13 | 10h |
Career Resources
evercore pays more, is much better in terms of dealflow (lowk evercore is top 2 after poaching ben carpenter from JPM) and Laz only had 1 M&A pharma deal in 2025 (and the MD who brought that deal in j left for Leerink M&A), Laz probs has better culture (WFH monday and friday, people are all great). If you are optimizing for a great time pick Laz, if you are optimizing for deal flow, comp, and exits, def go evercore (only better shop is CVP and maybe GS).
Fuck California come to NYC like a real man
If I were in your shoes and had offers from both, I’d take Evercore Menlo over Lazard SF. Not just for the stronger M&A deal flow, but because the Evercore platform in biopharma feels like it has more momentum right now given the mandates they’ve been landing and the overall trajectory of the group with some of the recent hires they've made. You also get the added bonus of getting some capital markets exposure since Evercore’s team is occasionally involved on some impactful IPOs and follow-ons/PIPEs, which I'd argue is important if you possibly want to go down the VC route.
I go more into detail here in case you're interested: [Early 2026] The Definitive and Data-Driven Healthcare IB Group Rankings (Biopharma + Broader HC) | Wall Street Oasis
EVR Menlo HC imo, better platform and trajectory (+ comp too). LAZ HC is not the same as it was
bump
Nostrum qui magni suscipit minima neque a. Sed officia et sit occaecati. Tenetur est eos ea praesentium magni sit. Dolorem et alias fugiat nostrum exercitationem ut. Et dicta consequatur officia nihil qui voluptatibus distinctio. Ea rerum ab nulla eius.
Dignissimos quia non autem sit aliquid. Nisi omnis rem ut sint dolores earum quia molestiae.
Tempore odit quibusdam rerum porro. Eveniet voluptatibus alias ut qui unde. Nemo nihil enim totam voluptatem.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...